A Pilot Study Evaluating the Signs and Symptoms of Seasonal Allergic Rhinoconjunctivitis Following Exposure in the Allergen BioCube

An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to Placebo

NCT01439815 ·Status: COMPLETED ·Phase: PHASE4

Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis

NCT00550875 ·Status: COMPLETED ·Phase: PHASE2

A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season

NCT00982163 ·Status: COMPLETED

A Multi-Center Study Evaluating the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle in the Conjunctival Allergen Challenge (CAC)

NCT01551056 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Study on the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of SHR-1819 Injection in Patients With Seasonal Allergic Rhinitis

NCT07091357 ·Status: RECRUITING ·Phase: PHASE2

A Survey of Adults and Children With Allergic Rhinoconjunctivitis (MK-7243-021)

NCT01535118 ·Status: COMPLETED

Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis

NCT02377895 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

NCT00652223 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

NCT00263549 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of an Allergen Vaccine in Grass-Pollen Allergy

NCT00293904 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts

NCT01012752 ·Status: UNKNOWN ·Phase: PHASE3

Dose-ranging Study to Assess the Efficacy and Safety of Ciclesonide HFA Nasal Aerosol in Adult and Adolescent Patients 12 Years and Older With Seasonal Allergic Rhinitis (SAR) (BY9010/M1-602)

NCT00807053 ·Status: COMPLETED ·Phase: PHASE2

Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis

NCT06577077 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Study Evaluating Nasal Symptoms Induced by a Nasal Allergen Challenge (NAC) To House Dust Mite Allergen

NCT01936818 ·Status: COMPLETED

A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

NCT04881461 ·Status: COMPLETED ·Phase: PHASE3

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).

NCT01451541 ·Status: COMPLETED ·Phase: PHASE3

Quality of Life in Allergic Rhinoconjunctivitis Patients Treated With Dialyzable Leukocyte Extracts

NCT02506998 ·Status: COMPLETED ·Phase: PHASE2

Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.

NCT02230475 ·Status: COMPLETED

Pilot Trial to Elaborate a Cutaneous Antigen Neutralization Test in Patients Suffering From Rhinoconjunctivitis

NCT00461721 ·Status: COMPLETED

A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and Cetirizine

NCT01103050 ·Status: COMPLETED ·Phase: PHASE2

A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)

NCT01458275 ·Status: COMPLETED ·Phase: PHASE3

Effect of a Nasal Bolus Allergen Challenge on Inflammatory Markers

NCT00483353 ·Status: COMPLETED ·Phase: PHASE1

EWO1 in Persistent Allergic Rhinitis Patients

NCT00153595 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)

NCT00092885 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis

NCT03887026 ·Status: COMPLETED ·Phase: PHASE2